EMA virtual technical media briefing on the RNA technology
EventHuman
- The original event time is:
- Friday, February 3, 2023 - 10:00 - 10:45 Amsterdam time (CET)
Date
- , -
Location
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
Event summary
The European Medicines Agency (EMA) held a technical media briefing on possible applications of RNA technology and the scientific and regulatory challenges that need to be addressed.
Prof. Steffen Thirstrup, EMA’s Chief Medical Officer, and Prof. Annemieke Aartsma-Rus, an expert in the field of RNA technology and rare diseases from Leiden University Medical Center, provided insights into research and regulation around RNA-based medicines. The press briefing, held in English, was moderated by Marie-Agnes Heine, Head of Communications at EMA.
The technical briefing followed a regulatory and scientific virtual conference on RNA-based medicines organised by EMA on 2 February.